Latent Tuberculosis Infection (LTBI) Testing Industry Research Report 2023

Latent Tuberculosis Infection (LTBI) Testing Industry Research Report 2023


The Latent Tuberculosis Infection (LTBI) Testing industry can be broken down into several segments, Tuberculin Skin Test (TST), Interferon Gamma Released Assay (IGRA), etc.
Across the world, the major players cover Qiagen, Oxford Immunotec, Sanofi, etc.
Diagnosing and treating latent tuberculosis (TB) infection (LTBI) is recognized by the World Health Organization as an important strategy to accelerate the decline in global TB and achieve TB elimination. Latent tuberculosis infection (LTBI) is defined as a state of persistent immune response to stimulation by Mycobacterium tuberculosis antigens without evidence of clinically manifested active tuberculosis (TB). Diagnosis and treatment for LTBI are important for TB, especially in high-risk populations. Tuberculin skin test (TST) and interferon-gamma release assays (IGRAs) are used to diagnose LTBI.

Highlights

The global Latent Tuberculosis Infection (LTBI) Testing market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
The detection industry of latent tuberculosis infection (LTBI) can be subdivided into several parts: tuberculin skin test (TST), interferon release test (IGRA), etc.
Globally, there are mainly Qiagen, Oxford Immunotec, Sanofi, etc.
Diagnosing and treating latent tuberculosis infection (LTBI) is an important strategy recognized by the World Health Organization to accelerate the decline of global tuberculosis and achieve the elimination of tuberculosis. Latent tuberculosis infection (LTBI) refers to the state of continuous immune response to the stimulation of Mycobacterium tuberculosis antigen in the absence of clinical evidence of active tuberculosis (TB). The diagnosis and treatment of long-term tuberculosis is very important for tuberculosis, especially for high-risk groups. Tuberculin skin tests (TST) and interferon release tests (IGRAs) were used to diagnose LTBI.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Latent Tuberculosis Infection (LTBI) Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Latent Tuberculosis Infection (LTBI) Testing.
The Latent Tuberculosis Infection (LTBI) Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Latent Tuberculosis Infection (LTBI) Testing market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Latent Tuberculosis Infection (LTBI) Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights


In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Qiagen
Sanofi
Oxford Immunotec
Thermo Fisher Scientific
Par Sterile
Bio-Rad Laboratories

Product Type Insights

Global markets are presented by Latent Tuberculosis Infection (LTBI) Testing type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Latent Tuberculosis Infection (LTBI) Testing are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Latent Tuberculosis Infection (LTBI) Testing segment by Type

Tuberculin Skin Test (TST)
Interferon Gamma Released Assay (IGRA)

Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Latent Tuberculosis Infection (LTBI) Testing market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Latent Tuberculosis Infection (LTBI) Testing market.
Latent Tuberculosis Infection (LTBI) Testing Segment by Application

Hospitals and Clinics
Diagnostic Laboratories
Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Latent Tuberculosis Infection (LTBI) Testing market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Latent Tuberculosis Infection (LTBI) Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Latent Tuberculosis Infection (LTBI) Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Latent Tuberculosis Infection (LTBI) Testing industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Latent Tuberculosis Infection (LTBI) Testing.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Latent Tuberculosis Infection (LTBI) Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.

Frequently Asked Questions

What factors will challenge the Product Name market growth?
Which end-use segment will expand at the fastest CAGR in the Product Name market?
Which are the emerging players in the Product Name market?
How concentrated is the Product Name market?
Which factors are positively contributing to the Product Name market growth?
Which are the novel product innovations in the Product Name market?
Which product segment will emerge as the most lucrative in the Product Name market?
Which factors are increasing the competition in the Product Name market?
Which are the strategic measures taken by the Product Name industry players?
Which region will witness inactive growth during the forecast period?
What key trends are likely to emerge in the Product Name market in the coming years?


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Latent Tuberculosis Infection (LTBI) Testing by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 Tuberculin Skin Test (TST)
1.2.3 Interferon Gamma Released Assay (IGRA)
2.3 Latent Tuberculosis Infection (LTBI) Testing by Application
2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
2.3.2 Hospitals and Clinics
2.3.3 Diagnostic Laboratories
2.3.4 Others
2.4 Assumptions and Limitations
3 Latent Tuberculosis Infection (LTBI) Testing Breakdown Data by Type
3.1 Global Latent Tuberculosis Infection (LTBI) Testing Historic Market Size by Type (2018-2023)
3.2 Global Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Type (2023-2028)
4 Latent Tuberculosis Infection (LTBI) Testing Breakdown Data by Application
4.1 Global Latent Tuberculosis Infection (LTBI) Testing Historic Market Size by Application (2018-2023)
4.2 Global Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Application (2018-2023)
5 Global Growth Trends
5.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Perspective (2018-2029)
5.2 Global Latent Tuberculosis Infection (LTBI) Testing Growth Trends by Region
5.2.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 Latent Tuberculosis Infection (LTBI) Testing Historic Market Size by Region (2018-2023)
5.2.3 Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Region (2024-2029)
5.3 Latent Tuberculosis Infection (LTBI) Testing Market Dynamics
5.3.1 Latent Tuberculosis Infection (LTBI) Testing Industry Trends
5.3.2 Latent Tuberculosis Infection (LTBI) Testing Market Drivers
5.3.3 Latent Tuberculosis Infection (LTBI) Testing Market Challenges
5.3.4 Latent Tuberculosis Infection (LTBI) Testing Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Latent Tuberculosis Infection (LTBI) Testing Players by Revenue
6.1.1 Global Top Latent Tuberculosis Infection (LTBI) Testing Players by Revenue (2018-2023)
6.1.2 Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Players (2018-2023)
6.2 Global Latent Tuberculosis Infection (LTBI) Testing Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Latent Tuberculosis Infection (LTBI) Testing Head office and Area Served
6.4 Global Latent Tuberculosis Infection (LTBI) Testing Players, Product Type & Application
6.5 Global Latent Tuberculosis Infection (LTBI) Testing Players, Date of Enter into This Industry
6.6 Global Latent Tuberculosis Infection (LTBI) Testing Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Latent Tuberculosis Infection (LTBI) Testing Market Size (2018-2029)
7.2 North America Latent Tuberculosis Infection (LTBI) Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2018-2023)
7.4 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 Europe
8.1 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size (2018-2029)
8.2 Europe Latent Tuberculosis Infection (LTBI) Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2018-2023)
8.4 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size (2018-2029)
9.2 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2018-2023)
9.4 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 Latin America
10.1 Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size (2018-2029)
10.2 Latin America Latent Tuberculosis Infection (LTBI) Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2018-2023)
10.4 Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size (2018-2029)
11.2 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2018-2023)
11.4 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 Players Profiled
11.1 Qiagen
11.1.1 Qiagen Company Detail
11.1.2 Qiagen Business Overview
11.1.3 Qiagen Latent Tuberculosis Infection (LTBI) Testing Introduction
11.1.4 Qiagen Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2017-2022)
11.1.5 Qiagen Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Detail
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Latent Tuberculosis Infection (LTBI) Testing Introduction
11.2.4 Sanofi Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2017-2022)
11.2.5 Sanofi Recent Development
11.3 Oxford Immunotec
11.3.1 Oxford Immunotec Company Detail
11.3.2 Oxford Immunotec Business Overview
11.3.3 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Introduction
11.3.4 Oxford Immunotec Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2017-2022)
11.3.5 Oxford Immunotec Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Introduction
11.4.4 Thermo Fisher Scientific Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2017-2022)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Par Sterile
11.5.1 Par Sterile Company Detail
11.5.2 Par Sterile Business Overview
11.5.3 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Introduction
11.5.4 Par Sterile Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2017-2022)
11.5.5 Par Sterile Recent Development
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Detail
11.6.2 Bio-Rad Laboratories Business Overview
11.6.3 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Introduction
11.6.4 Bio-Rad Laboratories Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2017-2022)
11.6.5 Bio-Rad Laboratories Recent Development
13 Report Conclusion
14 Disclaimer
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Type (2018-2023)
Table 7. Global Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Type (2024-2029)
Table 9. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Application (2018-2023)
Table 11. Global Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Application (2024-2029)
Table 13. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Region (2018-2023)
Table 16. Global Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Region (2024-2029)
Table 18. Latent Tuberculosis Infection (LTBI) Testing Market Trends
Table 19. Latent Tuberculosis Infection (LTBI) Testing Market Drivers
Table 20. Latent Tuberculosis Infection (LTBI) Testing Market Challenges
Table 21. Latent Tuberculosis Infection (LTBI) Testing Market Restraints
Table 22. Global Top Latent Tuberculosis Infection (LTBI) Testing Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Latent Tuberculosis Infection (LTBI) Testing Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Latent Tuberculosis Infection (LTBI) Testing, Headquarters and Area Served
Table 26. Global Latent Tuberculosis Infection (LTBI) Testing Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Latent Tuberculosis Infection (LTBI) Testing by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Latent Tuberculosis Infection (LTBI) Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Latent Tuberculosis Infection (LTBI) Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Latent Tuberculosis Infection (LTBI) Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2024-2029) & (US$ Million)
Table 45. Qiagen Company Detail
Table 46. Qiagen Business Overview
Table 47. Qiagen Latent Tuberculosis Infection (LTBI) Testing Product
Table 48. Qiagen Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2017-2022) & (US$ Million)
Table 49. Qiagen Recent Development
Table 50. Sanofi Company Detail
Table 51. Sanofi Business Overview
Table 52. Sanofi Latent Tuberculosis Infection (LTBI) Testing Product
Table 53. Sanofi Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2017-2022) & (US$ Million)
Table 54. Sanofi Recent Development
Table 55. Oxford Immunotec Company Detail
Table 56. Oxford Immunotec Business Overview
Table 57. Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Product
Table 58. Oxford Immunotec Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2017-2022) & (US$ Million)
Table 59. Oxford Immunotec Recent Development
Table 60. Thermo Fisher Scientific Company Detail
Table 61. Thermo Fisher Scientific Business Overview
Table 62. Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Product
Table 63. Thermo Fisher Scientific Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2017-2022) & (US$ Million)
Table 64. Thermo Fisher Scientific Recent Development
Table 65. Par Sterile Company Detail
Table 66. Par Sterile Business Overview
Table 67. Par Sterile Latent Tuberculosis Infection (LTBI) Testing Product
Table 68. Par Sterile Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2017-2022) & (US$ Million)
Table 69. Par Sterile Recent Development
Table 70. Bio-Rad Laboratories Company Detail
Table 71. Bio-Rad Laboratories Business Overview
Table 72. Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Product
Table 73. Bio-Rad Laboratories Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2017-2022) & (US$ Million)
Table 74. Bio-Rad Laboratories Recent Development
Table 75. Qiagen Company Information
Table 76. Qiagen Business Overview
Table 77. Qiagen Latent Tuberculosis Infection (LTBI) Testing Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2018-2023) & (US$ Million)
Table 78. Qiagen Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2018-2023) & (US$ Million) Portfolio
Table 79. Qiagen Recent Development
Table 80. Sanofi Company Information
Table 81. Sanofi Business Overview
Table 82. Sanofi Latent Tuberculosis Infection (LTBI) Testing Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2018-2023) & (US$ Million)
Table 83. Sanofi Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2018-2023) & (US$ Million) Portfolio
Table 84. Sanofi Recent Development
Table 85. Oxford Immunotec Company Information
Table 86. Oxford Immunotec Business Overview
Table 87. Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2018-2023) & (US$ Million)
Table 88. Oxford Immunotec Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2018-2023) & (US$ Million) Portfolio
Table 89. Oxford Immunotec Recent Development
Table 90. Thermo Fisher Scientific Company Information
Table 91. Thermo Fisher Scientific Business Overview
Table 92. Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2018-2023) & (US$ Million)
Table 93. Thermo Fisher Scientific Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2018-2023) & (US$ Million) Portfolio
Table 94. Thermo Fisher Scientific Recent Development
Table 95. Par Sterile Company Information
Table 96. Par Sterile Business Overview
Table 97. Par Sterile Latent Tuberculosis Infection (LTBI) Testing Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2018-2023) & (US$ Million)
Table 98. Par Sterile Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2018-2023) & (US$ Million) Portfolio
Table 99. Par Sterile Recent Development
Table 100. Bio-Rad Laboratories Company Information
Table 101. Bio-Rad Laboratories Business Overview
Table 102. Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2018-2023) & (US$ Million)
Table 103. Bio-Rad Laboratories Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2018-2023) & (US$ Million) Portfolio
Table 104. Bio-Rad Laboratories Recent Development
Table 105. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Latent Tuberculosis Infection (LTBI) Testing Product Picture
Figure 5. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Type: 2022 VS 2029
Figure 7. Tuberculin Skin Test (TST) Product Picture
Figure 8. Interferon Gamma Released Assay (IGRA) Product Picture
Figure 9. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2023-2029) & (US$ Million)
Figure 10. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Application: 2022 VS 2029
Figure 11. Hospitals and Clinics Product Picture
Figure 12. Diagnostic Laboratories Product Picture
Figure 13. Others Product Picture
Figure 14. Global Latent Tuberculosis Infection (LTBI) Testing Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Latent Tuberculosis Infection (LTBI) Testing Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Region: 2022 VS 2029
Figure 17. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Players in 2022
Figure 18. Global Latent Tuberculosis Infection (LTBI) Testing Players, Date of Enter into This Industry
Figure 19. Global Top 5 and 10 Latent Tuberculosis Infection (LTBI) Testing Players Market Share by Revenue in 2022
Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 21. North America Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Latent Tuberculosis Infection (LTBI) Testing Market Share by Country (2018-2029)
Figure 23. United States Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Latent Tuberculosis Infection (LTBI) Testing Market Share by Country (2018-2029)
Figure 27. Germany Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Share by Country (2018-2029)
Figure 35. China Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Japan Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. South Korea Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. India Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Australia Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Latent Tuberculosis Infection (LTBI) Testing Market Share by Country (2018-2029)
Figure 43. Mexico Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Brazil Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Share by Country (2018-2029)
Figure 47. Turkey Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. UAE Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Qiagen Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2018-2023)
Figure 51. Sanofi Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2018-2023)
Figure 52. Oxford Immunotec Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2018-2023)
Figure 53. Thermo Fisher Scientific Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2018-2023)
Figure 54. Par Sterile Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2018-2023)
Figure 55. Bio-Rad Laboratories Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2018-2023)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings